HR 421
115th Congress
House
Health
Drug safety, medical device, and laboratory regulation
Employee benefits and pensions
Family planning and birth control
Health care costs and insurance
Prescription drugs
User charges and fees
Allowing Greater Access to Safe and Effective Contraception Act
Introduced: January 10, 2017
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 26, 2017
Referred to the Subcommittee on Health.
Jan 25, 2017
Referred to the Subcommittee on Health.
Jan 10, 2017
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 10, 2017
Introduced in House
Plain-English summary
Allowing Greater Access to Safe and Effective Contraception Act
This bill requires the Food and Drug Administration (FDA) to prioritize review of supplemental drug applications (applications to modify the approved use of a drug) for contraceptive drugs intended for routine use that would be available to individuals aged 18 and older without a prescription. The FDA must waive user fees for such supplemental drug applications. Any drug that is eligible for this priority review must be a prescription drug for individuals under age 18.
This bill repeals provisions of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 to allow health savings accounts and health flexible spending accounts (HFSAs) to be used to pay for medicine without a prescription and to remove the limit on salary reduction contributions to a HFSA under a cafeteria plan, effective as if the provisions had never been enacted.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4